Amyloid Neuropathies, Familial - 22 Studies Found
Enrolling by invitation |
: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran) : Amyloidosis : 2015-07-16 : Drug: Patisiran (ALN-TTR02) administered by intravenous (IV) infusion |
Completed |
: Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers :
|